Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early

The diagnostic odyssey rare disease patient face can be long and daunting. Centogene is trying to help these patients find answer more quickly through its genetic diagnostics. The company has been focused on getting beyond the noise generated by the rapid increase in the volume of data to get accurate understanding of a patient’s genetics and helping doctors obtain actionable information. Strengthened with a recent $28 million financing, the company is expanding its presence in the United States. We spoke to Arndt Rolfs, CEO of Centogene, about the company’s genetic diagnostic services, its expansion plans, and the competitive advantage it believes it holds in its proprietary data.